aspirin has been researched along with Laryngeal Diseases in 3 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Laryngeal Diseases: Pathological processes involving any part of the LARYNX which coordinates many functions such as voice production, breathing, swallowing, and coughing.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This report describes a case of a probable interaction between topical econazole lotion 1% and acenocoumarol that resulted in overanticoagulation and a life-threatening laryngeal hematoma in this elderly patient." | 7.74 | Laryngeal dyspnea in relation to an interaction between acenocoumarol and topical econazole lotion. ( Escarment, J; Lions, C; Ould-Ahmed, M; Petitjeans, F; Wey, PF, 2008) |
| "This report describes a case of a probable interaction between topical econazole lotion 1% and acenocoumarol that resulted in overanticoagulation and a life-threatening laryngeal hematoma in this elderly patient." | 3.74 | Laryngeal dyspnea in relation to an interaction between acenocoumarol and topical econazole lotion. ( Escarment, J; Lions, C; Ould-Ahmed, M; Petitjeans, F; Wey, PF, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Francis, DO | 1 |
| Dang, JH | 1 |
| Fritz, MA | 1 |
| Garrett, CG | 1 |
| Wey, PF | 1 |
| Petitjeans, F | 1 |
| Lions, C | 1 |
| Ould-Ahmed, M | 1 |
| Escarment, J | 1 |
| Jacobs, JC | 1 |
| Hui, RM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Laryngeal Manifestations of Connective Tissue Diseases[NCT04582292] | 50 participants (Anticipated) | Observational [Patient Registry] | 2020-11-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for aspirin and Laryngeal Diseases
| Article | Year |
|---|---|
Antiplatelet and anticoagulation therapy in microlaryngeal surgery.
Topics: Adult; Aged; Aspirin; Clopidogrel; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Incidence | 2014 |
Laryngeal dyspnea in relation to an interaction between acenocoumarol and topical econazole lotion.
Topics: Acenocoumarol; Administration, Topical; Aged, 80 and over; Anticoagulants; Antifungal Agents; Aspiri | 2008 |
Cricoarytenoid arthritis and airway obstruction in juvenile rheumatoid arthritis.
Topics: Airway Obstruction; Arthritis, Juvenile; Aspirin; Child, Preschool; Dexamethasone; Humans; Laryngeal | 1977 |